Meeting Program
| To view program in "24 hour" time (international) click here. |
| Wednesday, October 22 | ||
|---|---|---|
| 2:00 - 6:00 PM | Registration | |
| 6:00 - 7:00 PM |
Transportation to Dinner Event |
|
| 7:00 - 9:00 PM |
Joint Dinner with Grand Challenges in Global Health Conference NOTE: Dress code for the October 22nd dinner will apply for all participants: for men, business pants and open neck shirt is fine. For ladies, a smart dress is perfect. |
|
| Thursday, October 23 | ||
| 7:00 - 8:00 AM | Breakfast | |
| 7:00 - 8:00 AM | Poster Setup | |
| 8:00 - 11:30 AM |
Infection Biology Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008 |
|
|
Craig R. Roy,
Yale University School of Medicine
Modulation of Host Cell Functions by Type IV Effector Proteins |
||
|
Dana Philpott,
University of Toronto
Nod-Like Receptors |
||
|
Jean-Laurent Casanova,
INSERM U 550 Faculté de Médecine Necker
Genetic Susceptibility to Infectious Diseases |
||
|
Arturo Zychlinsky,
Max Plank Institute for Infection Biology
Neutrophil Extracellular Traps |
||
| 9:20 - 9:40 AM | Coffee Break | |
| 11:30 AM- 12:30 PM | Lunch | |
| 12:00 - 2:00 PM |
Poster Session 1 Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008 |
|
| 2:00 - 4:00 PM |
HIV Drug Resistance Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008 |
|
|
Robert F. Siliciano†,
Johns Hopkins School of Medicine
Reservoirs and the Problem of Virus Eradication in Patients |
||
|
Edward V. Arnold,
Rutgers University
RT Structure and Structure-Guided Design of Novel Inhibitors Targeting Multiple Sites |
||
|
Stephen Hughes,
NCI-Frederick, NIH
HIV-1 RT Drug Resistance and Drug Development |
||
| 4:00 - 4:30 PM | Coffee Break | |
| 4:30 - 6:30 PM |
Workshop 1: TB |
|
|
Clifton E. Barry III,
NIAID, National Institutes of Health
|
||
|
Short Talks to be Chosen from Abstracts,
|
||
| Friday, October 24 | ||
| 7:00 - 8:00 AM | Breakfast | |
| 7:00 - 8:00 AM | Poster Setup | |
| 8:00 - 11:30 AM |
Malaria Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008 |
|
|
Robert Ménard,
Institut Pasteur
In vivo Imaging of Plasmodium Pre-erythrocytic Stages in a Rodent Model |
||
|
Louis Schofield,
Walter and Eliza Hall Institute of Medical Research
Malaria and Vaccines |
||
|
Daniel E. Goldberg,
Washington University
Characterization of a Potential Drug Target: Plasmodium Calpain |
||
|
Alan Cowman,
Walter and Eliza Hall Institute of Medical Research
Invasion and Remodeling of the Human Erythrocyte by the Malaria Parasite |
||
|
Sumalee Kamchonwongpaisan,
BIOTEC, Thailand National Science and Technology Development Agency
Basic Understanding of Artemisinin Action against Plasmodium falciparum In Vitro |
||
|
Yongyuth Yuthavong,
BIOTEC, Thailand National Science and Technology Development Agency
Development of Target-Based Antimalarials |
||
| 9:20 - 9:40 AM | Coffee Break | |
| 11:30 AM- 12:30 PM | Lunch | |
| 12:00 - 2:00 PM |
Poster Session 2 Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008 |
|
| 2:00 - 5:00 PM |
Diarrhea and Vaccines Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008 |
|
|
E. Peter Greenberg,
University of Washington
WHAT'S NEW IN ACYL-HOMOSERINE LACTONE QUORUM SENSING: STRANGE SIGNALS AND STRANGE RECEPTORS |
||
|
Julian Guttman,
Simon Fraser University
Epithelial Cell Alterations that Influence Diarrhea Generation During Attaching and Effacing Bacterial Infections |
||
|
Philippe J. Sansonetti,
Institut Pasteur
Shigella : a tool box to tinker with the host immune response. |
||
|
John J. Mekalanos,
Harvard Medical School
Cholera |
||
| 3:20 - 3:40 PM | Coffee Break | |
| Saturday, October 25 | ||
| 7:00 - 8:00 AM | Breakfast | |
| 7:00 - 8:00 AM | Poster Setup | |
| 8:00 - 11:30 AM |
TB (and XDR) Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008 |
|
|
Megan Murray,
Harvard School of Public Health
Title to be Determined |
||
|
Nacer Lounis,
Tibotec
Diarylquinolines Have the Potential to Shorten TB Treatment Duration |
||
|
William R. Jacobs, Jr.,
Albert Einstein College of Medicine
IKEPLUS, A Recombinant M. smegmatis that Elicits Bacteriocidal Immunity against Virulent M. tuberculosis |
||
|
Valerie Mizrahi,
University of the Witwatersrand - MMRU
Environment-Dependent Mutators and their Role in the Evolution of Drug Resistance in Mycobacterium tuberculosis |
||
|
Douglas B. Young,
Imperial College London
TB Drugs |
||
| 9:20 - 9:40 AM | Coffee Break | |
| 11:30 AM- 12:30 PM | Lunch | |
| 12:00 - 2:00 PM |
Poster Session 3 Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008 |
|
| 2:00 - 5:00 PM |
Respiratory Pathogens Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008 |
|
|
Maria Rescigno,
European Institute of Oncology
Handling of Bacteria by Dendritic Cells at Mucosal Surfaces |
||
|
Birgitta Henriques-Normark,
Karolinska Institutet
The role of pneumococcal pili in Carriage and in Invasive Disease |
||
|
Scott D. Gray-Owen,
University of Toronto
The Pathogenic Neisseria: Dancing with Humans |
||
|
Jeremy Farrar,
Oxford University Clinical Research Unit - Hospital for Tropical Diseases
Globalization and Infectious Diseases: A Threat and an Opportunity for Collaborative Clinical Science |
||
|
Joseph DeRisi†,
University of California, San Francisco
Title to be Determined |
||
| 3:20 - 3:40 PM | Coffee Break | |
| 5:30 - 7:30 PM |
Workshop 2: Malaria |
|
|
Brendan S. Crabb,
Burnet Institute
|
||
|
Short Talks to be Chosen from Abstracts,
|
||
| Sunday, October 26 | ||
| 7:00 - 8:00 AM | Breakfast | |
| 8:00 - 11:30 AM |
Vaccines Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008 |
|
|
Gordon Dougan,
Wellcome Trust Sanger Institute
Vaccines against Invasive Salmonellosis |
||
|
Cecil Czerkinsky,
International Vaccine Institute
Mucosal Immunity and Vaccine Development |
||
|
Rino Rappuoli,
Novartis Vaccines & Diagnostics
Meringo coccus and Neglected Diseases |
||
|
Adrian V.S. Hill,
Jenner Institute, Oxford University
Vectored Vaccines against Intracellular Pathogens |
||
|
Stefan H.E. Kaufmann,
Max Planck Institute for Infection Biology-Berlin
Translating Basic Research in Tuberculosis into Vaccine and Biomarker Development |
||
| 9:20 - 9:40 AM | Coffee Break | |
| 11:30 AM- 2:00 PM | On Own for Lunch | |
| 2:00 - 4:00 PM |
Workshop 3: HIV |
|
|
Peter D. Kwong,
National Institutes of Health
Targeting the Receptor-Binding Sites on HIV-1 gp120 |
||
|
Short Talks to be Chosen from Abstracts,
|
||
| 4:00 - 4:30 PM | Coffee Break | |
| 4:30 - 7:00 PM |
Combating Emerging Pathogens Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008 |
|
|
Robert E.W. Hancock,
University of British Columbia
Selectively Modulating Innate Immunity |
||
|
Sarah Randolph,
University of Oxford
Predicting Arrival, Establishment and Spread of Exotic Diseases |
||
|
Stefan H.I. Kappe,
Seattle Biomedical Research Institute
Malaria Vaccine in Mice |
||
| 7:00 - 8:00 PM | Social Hour w/ Lite Bites | |
| 8:00 - 11:00 PM | Entertainment | |
| Monday, October 27 | ||
| Departure | ||
| *=Session Chair †=Speaker invited, not yet responded. | ||
Keystone Symposia would like to thank the sponsor of this meeting for their generous support:

We gratefully acknowledge additional support for this conference from:
![]() |
We gratefully acknowledge the companies that provide Keystone Symposia with additional meeting support, including marketing and advertising...
Click here to view these companies





